Despite revenue missing estimates and declining 11.9% year-over-year, Kemper delivered a strong EPS beat of 53.03% above consensus. The company improved its combined ratio to 99.2% (better than 101% estimate) and showed growth in commercial auto premiums (+11.1%) and life insurance premiums (+15.9%). The stock has gained 23.9% over the past month and carries a Zacks Rank #2 (Buy) rating, indicating positive near-term outlook.
Mixed results: strong EPS beat (+53%) and Zacks Rank #2 (Buy) rating support positive outlook, but significant revenue miss, year-to-date underperformance (-17.6% vs S&P 500 +7.8%), and weak industry ranking (bottom 35%) create headwinds. Sustainability depends on management commentary.
Strong positive Earnings ESP of +53.61% combined with Zacks Rank #2 (Buy) indicates high probability of beating consensus EPS estimate of $0.66. Recent analyst revisions have become more bullish, and the company has a history of significant beats (last quarter +40.63% surprise).
Company faces federal securities investigation for potential violations related to undisclosed increased loss costs from higher liability limits. Stock declined 10% following disclosure of elevated attorney involvement and claims costs that developed over several quarters, suggesting possible mismanagement or inadequate prior disclosure.
Articles that tag KMPB but are mainly about other companies.
Expected to report 100% year-over-year EPS growth with stable consensus estimates over the last 30 days, indicating confidence in earnings delivery. However, revenue decline of 11.5% provides some offset to the positive earnings outlook.
Expected to report 100% year-over-year earnings growth but faces declining revenues (down 11.5% YoY). Mixed signals with strong earnings growth offset by revenue contraction warrant a neutral stance pending actual results.
Expected 100% YoY earnings growth, positive Earnings ESP of +53.61%, and Zacks Rank #2 (Buy) indicate strong likelihood of beating consensus EPS estimates.
Kemper is expected to report earnings of $0.66 per share with 100% year-over-year growth, but revenues are projected to decline 11.5%. The unchanged consensus estimate over 30 days suggests stable but unexciting expectations, and the weak industry outlook provides limited tailwinds.
Expected to report earnings of $0.66 per share (100% year-over-year increase), but revenues are projected to decline 11.5% year-over-year to $1.1 billion. Mixed signals with strong earnings growth offset by revenue decline and unchanged consensus estimates over 30 days.
Expected to report strong EPS growth of 66.7% year-over-year, but revenues are projected to decline 11.5%. Mixed signals with earnings strength offset by revenue weakness. Consensus estimates unchanged over last 30 days, indicating stability but no momentum.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology